BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1670744)

  • 1. A double-blind comparative study of doxazosin and prazosin when administered with beta-blockers or diuretics.
    de Planque BA
    Am Heart J; 1991 Jan; 121(1 Pt 2):304-11. PubMed ID: 1670744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with doxazosin in general medical practice.
    Rosenthal J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapy.
    Rosenthal J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1763-6. PubMed ID: 2904747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, noncomparative study of doxazosin in essential hypertension: experience in general practice in The Netherlands.
    Naber FB
    Am Heart J; 1991 Jan; 121(1 Pt 2):273-9. PubMed ID: 1824650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers.
    Englert RG; Barlage U
    Am Heart J; 1991 Jan; 121(1 Pt 2):311-6. PubMed ID: 1670745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    Englert RG; Mauersberger H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of doxazosin in hypertension therapy.
    Hayduk K
    Am J Cardiol; 1987 May; 59(14):35G-39G. PubMed ID: 2884851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
    van den Hogen AL
    Am Heart J; 1988 Dec; 116(6 Pt 2):1757-62. PubMed ID: 2904746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of doxazosin to the treatment regimen of hypertensive patients not responsive to nifedipine.
    Lindner UK; von Manteuffel GE; Stafunsky M
    Am Heart J; 1988 Dec; 116(6 Pt 2):1814-20. PubMed ID: 2904756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
    Searle M; Dathan R; Dean S; Christensen CC; Westheim A
    Eur J Clin Pharmacol; 1990; 39(3):299-300. PubMed ID: 2147909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with doxazosin in general medical practice in The Netherlands.
    Harmse DP
    Am Heart J; 1991 Jan; 121(1 Pt 2):341-5. PubMed ID: 1824658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter study of doxazosin in the treatment of severe essential hypertension.
    Soltero I; Guevara J; Silva H; Velasco M
    Am Heart J; 1988 Dec; 116(6 Pt 2):1767-71. PubMed ID: 2904748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication.
    Catalano M; Libretti A
    Am Heart J; 1991 Jan; 121(1 Pt 2):367-71. PubMed ID: 1824663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term study of doxazosin in the treatment of mild or moderate essential hypertension in general medical practice.
    Manos J
    Am Heart J; 1991 Jan; 121(1 Pt 2):346-51. PubMed ID: 1824659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
    Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin in the treatment of essential hypertension in general medical practice in Latin America.
    Silva H; Fonseca R; Marshall D
    Am Heart J; 1991 Jan; 121(1 Pt 2):329-35. PubMed ID: 1824656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.
    Taylor SH; Lee PS; Sharma SK
    Am Heart J; 1988 Dec; 116(6 Pt 2):1820-5. PubMed ID: 2904757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.